(A) Expression of KLRG1, IL-7Rα and tdTomato in splenic effector
OT-I cell subsets 6 days p.i. with LM (pre-transfer) and 22 days post-transfer
(day 28 p.i.).
(B) Development of exKLRG1 memory cells (day 28 p.i.) from three
different effector OT-I cell subsets 6 days p.i. with LM.
(C) Expression of KLRG1, IL-7Rα, tdTomato, CD62L and
CX3CR1 in splenic effector OT-I cell subsets 9 days p.i. with LM
(pre-transfer) and 26 days post-transfer (day 35 p.i.).
(D) Development of exKLRG1 memory cells (day 35 p.i.) from three
different effector OT-I cell subsets 9 days p.i. with LM.
(E) Expression of CX3CR1 and CD62L in KLRG1+ and
exKLRG1 memory cells 26 days post transfer of day 9 Tdpe cells. Host
CD8+ T cells served as a control (gray line).
(F) Expression of CX3CR1 and CD62L in exKLRG1 and
KLRG1− Reporter− memory cells 26 days
post transfer of day 9 Tmpe cells. Host CD8+ T cells served as a
control (gray line).
Mean ± SEM are shown. * P < 0.05 and **
P < 0.01 (unpaired two-tailed Student’s
t-test). Data are representative of two independent
experiments with 3–4 mice. See also Figure S4.